<DOC>
	<DOC>NCT01560234</DOC>
	<brief_summary>This study will investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of AZD8848 in healthy subjects.</brief_summary>
	<brief_title>AZD8848 Single Ascending Dose Study</brief_title>
	<detailed_description>A Double-blind, Placebo-controlled, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Inhaled Doses of AZD8848 in Healthy Subjects</detailed_description>
	<criteria>Healthy men or women aged 18 to 45 years (inclusive) with suitable veins for cannulation or repeated venipuncture. Women can be of childbearing potential and must have been stable on a highly effective contraceptive method for at least 3 months prior to Visit 1 (screening) and be willing to continue on the chosen contraceptive method Male subjects should be willing to use a condom (with spermicide) to prevent pregnancy and drug exposure of a female partner and refrain from donating sperm or fathering a child from the day of the investigational product administration until 3 months Have a body mass index (BMI) between 18 and 30 kg/m2 and weigh at least 50 kg and no more than 100 kg Ability to produce sputum of good enough quality for assessment of biomarkers Abnormal vital signs, after 10 minutes supine rest, defined as any of the following (SBP &gt; 140 mmHg, Diastolic blood pressure (DBP) &gt; 90 mmHg, Heart rate &lt; 40 or &gt; 85 beats per minute) Prolonged QTcF &gt; 450 ms or shortened QTcF &lt; 340 ms or family history of long QT syndrome History of severe allergy/hypersensitivity or ongoing allergy/hypersensitivity, as judged by the Investigator or history of hypersensitivity to drugs with a similar chemical structure or class as AZD8848 History of additional risk factors for Torsade de pointes (e.g., heart failure, hypokalaemia, family history of Long QT syndrome, or sudden death) History of asthma or allergic rhinitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>healthy</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>pharmacodynamic</keyword>
	<keyword>inhaled</keyword>
</DOC>